BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16906883)

  • 1. Minimal model for tumor angiogenesis.
    Kevrekidis PG; Whitaker N; Good DJ; Herring GJ
    Phys Rev E Stat Nonlin Soft Matter Phys; 2006 Jun; 73(6 Pt 1):061926. PubMed ID: 16906883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on endogenous inhibitors of angiogenesis.
    Sato Y
    Endothelium; 2006; 13(2):147-55. PubMed ID: 16728331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modeling of the onset of capillary formation initiating angiogenesis.
    Levine HA; Sleeman BD; Nilsen-Hamilton M
    J Math Biol; 2001 Mar; 42(3):195-238. PubMed ID: 11315313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model for capillary formation and development in tumor angiogenesis: a review.
    Pamuk S
    Chemotherapy; 2006; 52(1):35-7. PubMed ID: 16340197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy.
    Billy F; Ribba B; Saut O; Morre-Trouilhet H; Colin T; Bresch D; Boissel JP; Grenier E; Flandrois JP
    J Theor Biol; 2009 Oct; 260(4):545-62. PubMed ID: 19615383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascularization in tumor growth.
    Scalerandi M; Sansone BC
    Phys Rev Lett; 2002 Nov; 89(21):218101. PubMed ID: 12443451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling of tumor-induced angiogenesis.
    Mantzaris NV; Webb S; Othmer HG
    J Math Biol; 2004 Aug; 49(2):111-87. PubMed ID: 15293017
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular Detransformation for Cancer Therapy.
    Fan Y
    Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour angiogenesis.
    Fox SB; Gatter KC; Harris AL
    J Pathol; 1996 Jul; 179(3):232-7. PubMed ID: 8774475
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of taxis and synergy in angiogenesis.
    Capogrosso Sansone B; Scalerandi M; Condat CA
    Phys Rev Lett; 2001 Sep; 87(12):128102. PubMed ID: 11580561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lattice and non-lattice models of tumour angiogenesis.
    Plank MJ; Sleeman BD
    Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modelling, simulation and prediction of tumour-induced angiogenesis.
    Chaplain MA; Anderson AR
    Invasion Metastasis; 1996; 16(4-5):222-34. PubMed ID: 9311387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advancement of endogenous angiogenesis inhibitors].
    Wu JX; Xu BL; Huang WL
    Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hanging-drop multicellular spheroids as a model of tumour angiogenesis.
    Timmins NE; Dietmair S; Nielsen LK
    Angiogenesis; 2004; 7(2):97-103. PubMed ID: 15516830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-dimensional model for studying tumor angiogenesis inhibitors.
    Gao P; Yang JL; Wang H; Wu XD; Jiao SC
    Cancer Invest; 2013 Jun; 31(5):346-58. PubMed ID: 23641911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.